Adnan Custovic1,2, Danielle Belgrave1, Lijing Lin3, Eteri Bakhsoliani2,4, Aurica G Telcian2,4, Roberto Solari2,4, Clare S Murray5, Ross P Walton2,4, John Curtin5, Michael R Edwards2,4, Angela Simpson5, Magnus Rattray3, Sebastian L Johnston2,4. 1. 1 Section of Paediatrics, Department of Medicine, Imperial College London, London, United Kingdom. 2. 2 MRC and Asthma UK Centre in Allergic Mechanisms of Asthma, London, United Kingdom. 3. 3 Faculty of Biology, Medicine and Health, University of Manchester, Manchester, United Kingdom. 4. 4 COPD and Asthma Section, National Heart and Lung Institute, Imperial College London, London, United Kingdom; and. 5. 5 Division of Infection, Immunity and Respiratory Medicine, Faculty of Biology, Medicine and Health, Manchester Academic Health Sciences Centre, University of Manchester and University Hospital of South Manchester NHS Foundation Trust, Manchester, United Kingdom.
Abstract
RATIONALE: Immunophenotypes of antiviral responses, and their relationship with asthma, allergy, and lower respiratory tract infections, are poorly understood. OBJECTIVES: We characterized multiple cytokine responses of peripheral blood mononuclear cells to rhinovirus stimulation, and their relationship with clinical outcomes. METHODS: In a population-based birth cohort, we measured 28 cytokines after stimulation with rhinovirus-16 in 307 children aged 11 years. We used machine learning to identify patterns of cytokine responses, and related these patterns to clinical outcomes, using longitudinal models. We also ascertained phytohemagglutinin-induced T-helper cell type 2 (Th2)-cytokine responses (PHA-Th2). MEASUREMENTS AND MAIN RESULTS: We identified six clusters of children based on their rhinovirus-16 responses, which were differentiated by the expression of four cytokine/chemokine groups: interferon-related (IFN), proinflammatory (Inflam), Th2-chemokine (Th2-chem), and regulatory (Reg). Clusters differed in their clinical characteristics. Children with an IFNmodInflamhighestTh2-chemhighestReghighest rhinovirus-16-induced pattern had a PHA-Th2low response, and a very low asthma risk (odds ratio [OR], 0.08; 95% confidence interval [CI], 0.01-0.81; P = 0.03). Two clusters had a high risk of asthma and allergic sensitization, but with different trajectories from infancy to adolescence. The IFNlowestInflamhighTh2-chemlowRegmod cluster exhibited a PHA-Th2lowest response and was associated with early-onset asthma and sensitization, and the highest risk of asthma exacerbations (OR, 1.37; 95% CI, 1.07-1.76; P = 0.014) and lower respiratory tract infection hospitalizations (OR, 2.40; 95% CI, 1.26-4.58; P = 0.008) throughout childhood. In contrast, the IFNhighestInflammodTh2-chemmodReghigh cluster with a rhinovirus-16-cytokine pattern was characterized by a PHA-Th2highest response, and a low prevalence of asthma/sensitization in infancy that increased sharply to become the highest among all clusters by adolescence (but with a low risk of asthma exacerbations). CONCLUSIONS: Early-onset troublesome asthma with early-life sensitization, later-onset milder allergic asthma, and disease protection are each associated with different patterns of rhinovirus-induced immune responses.
RATIONALE: Immunophenotypes of antiviral responses, and their relationship with asthma, allergy, and lower respiratory tract infections, are poorly understood. OBJECTIVES: We characterized multiple cytokine responses of peripheral blood mononuclear cells to rhinovirus stimulation, and their relationship with clinical outcomes. METHODS: In a population-based birth cohort, we measured 28 cytokines after stimulation with rhinovirus-16 in 307 children aged 11 years. We used machine learning to identify patterns of cytokine responses, and related these patterns to clinical outcomes, using longitudinal models. We also ascertained phytohemagglutinin-induced T-helper cell type 2 (Th2)-cytokine responses (PHA-Th2). MEASUREMENTS AND MAIN RESULTS: We identified six clusters of children based on their rhinovirus-16 responses, which were differentiated by the expression of four cytokine/chemokine groups: interferon-related (IFN), proinflammatory (Inflam), Th2-chemokine (Th2-chem), and regulatory (Reg). Clusters differed in their clinical characteristics. Children with an IFNmodInflamhighestTh2-chemhighestReghighest rhinovirus-16-induced pattern had a PHA-Th2low response, and a very low asthma risk (odds ratio [OR], 0.08; 95% confidence interval [CI], 0.01-0.81; P = 0.03). Two clusters had a high risk of asthma and allergic sensitization, but with different trajectories from infancy to adolescence. The IFNlowestInflamhighTh2-chemlowRegmod cluster exhibited a PHA-Th2lowest response and was associated with early-onset asthma and sensitization, and the highest risk of asthma exacerbations (OR, 1.37; 95% CI, 1.07-1.76; P = 0.014) and lower respiratory tract infection hospitalizations (OR, 2.40; 95% CI, 1.26-4.58; P = 0.008) throughout childhood. In contrast, the IFNhighestInflammodTh2-chemmodReghigh cluster with a rhinovirus-16-cytokine pattern was characterized by a PHA-Th2highest response, and a low prevalence of asthma/sensitization in infancy that increased sharply to become the highest among all clusters by adolescence (but with a low risk of asthma exacerbations). CONCLUSIONS: Early-onset troublesome asthma with early-life sensitization, later-onset milder allergic asthma, and disease protection are each associated with different patterns of rhinovirus-induced immune responses.
Authors: James E Gern; Agustin Calatroni; Katy F Jaffee; Henry Lynn; Amy Dresen; William W Cruikshank; Howard M Lederman; Hugh A Sampson; Wayne Shreffler; Leonard B Bacharier; Peter J Gergen; Diane R Gold; Meyer Kattan; George T O'Connor; Megan T Sandel; Robert A Wood; Gordon R Bloomberg Journal: J Allergy Clin Immunol Date: 2017-01-13 Impact factor: 10.793
Authors: Kohei Hasegawa; Jane C Bittner; Stephanie A Nonas; Samantha J Stoll; Taketo Watase; Susan Gabriel; Vivian Herrera; Carlos A Camargo Journal: J Allergy Clin Immunol Pract Date: 2015-05-28
Authors: Michelle A Gill; Gagan Bajwa; Tiffany A George; Caroline C Dong; Irene I Dougherty; Nan Jiang; Vanthaya N Gan; Rebecca S Gruchalla Journal: J Immunol Date: 2010-04-21 Impact factor: 5.422
Authors: Neil W Johnston; Sebastian L Johnston; Joanne M Duncan; Justina M Greene; Tatiana Kebadze; Paul K Keith; Madan Roy; Susan Waserman; Malcolm R Sears Journal: J Allergy Clin Immunol Date: 2005-01 Impact factor: 10.793
Authors: N Lazic; G Roberts; A Custovic; D Belgrave; C M Bishop; J Winn; J A Curtin; S Hasan Arshad; A Simpson Journal: Allergy Date: 2013-04-29 Impact factor: 13.146
Authors: Karin C Lødrup Carlsen; Stephanie Roll; Kai-Håkon Carlsen; Petter Mowinckel; Alet H Wijga; Bert Brunekreef; Maties Torrent; Graham Roberts; S Hasan Arshad; Inger Kull; Ursula Krämer; Andrea von Berg; Esben Eller; Arne Høst; Claudia Kuehni; Ben Spycher; Jordi Sunyer; Chih-Mei Chen; Andreas Reich; Anna Asarnoj; Carmen Puig; Olf Herbarth; Jestinah M Mahachie John; Kristel Van Steen; Stefan N Willich; Ulrich Wahn; Susanne Lau; Thomas Keil Journal: PLoS One Date: 2012-08-29 Impact factor: 3.240
Authors: Spyridon Megremis; Katarzyna Niespodziana; Clarissa Cabauatan; Paraskevi Xepapadaki; Marek L Kowalski; Tuomas Jartti; Claus Bachert; Susetta Finotto; Peter West; Sofia Stamataki; Anna Lewandowska-Polak; Heikki Lukkarinen; Nan Zhang; Theodor Zimmermann; Frank Stolz; Angela Neubauer; Mübeccel Akdis; Evangelos Andreakos; Rudolf Valenta; Nikolaos G Papadopoulos Journal: Am J Respir Crit Care Med Date: 2018-12-15 Impact factor: 21.405
Authors: Kohei Hasegawa; Claire E Hoptay; Brennan Harmon; Juan C Celedón; Jonathan M Mansbach; Pedro A Piedra; Robert J Freishtat; Carlos A Camargo Journal: Allergy Date: 2019-02-01 Impact factor: 13.146
Authors: Lyndsey M Muehling; Peter W Heymann; Holliday Carper; Deborah D Murphy; Evan Rajadhyaksha; Joshua Kennedy; Stephen V Early; Manuel Soto-Quiros; Lydiana Avila; Lisa Workman; Thomas A E Platts-Mills; Judith A Woodfolk Journal: Clin Exp Allergy Date: 2022-06-06 Impact factor: 5.401
Authors: Matthew C Altman; Avraham Beigelman; Christina Ciaccio; James E Gern; Peter W Heymann; Daniel J Jackson; Joshua L Kennedy; Kirsten Kloepfer; Robert F Lemanske; Laurie M McWilliams; Lyndsey Muehling; Christy Nance; R Stokes Peebles Journal: J Allergy Clin Immunol Date: 2020-01-09 Impact factor: 14.290
Authors: Lisa M Jurak; Yang Xi; Megan Landgraf; Melanie L Carroll; Liisa Murray; John W Upham Journal: Front Immunol Date: 2018-08-16 Impact factor: 7.561